GENITOURINARY CANCERS

Latest News

FDA Approves Label Update But Not Expansion for Talazoparib/Enzalutamide in mCRPC
FDA Approves Label Update But Not Expansion for Talazoparib/Enzalutamide in mCRPC

June 17th 2025

FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding non-HRR patients.

FDA Approves Intravesical Mitomycin in Non–Muscle-Invasive Bladder Cancer
FDA Approves Intravesical Mitomycin in Non–Muscle-Invasive Bladder Cancer

June 12th 2025

CREST Trial: Sasanlimab/BCG Improves NMIBC Outcomes
CREST Trial: Sasanlimab/BCG Improves NMIBC Outcomes

June 11th 2025

Sacituzumab/Pembrolizumab Combo Shows Promise in Bladder Cancer
Sacituzumab/Pembrolizumab Combo Shows Promise in Bladder Cancer

June 10th 2025

ENVISION: UGN-102 Shows Strong Response in Recurrent NMIBC
ENVISION: UGN-102 Shows Strong Response in Recurrent NMIBC

June 9th 2025

More News